Lipoprotein(a) and SARS-CoV-2 infections: Risk for ischemic heart disease and thromboembolic events. (August 2022) - Di Maio, S.; Lamina, C.; Coassin, S.; Forer, L.; Würzner, R.; Schönherr, S.; Kronenberg, F.